PSA Vice President Professor Mark Naunton MPS[/caption]
Dr Louise Schaper at PSA25[/caption]
These are the reasons people misuse prescription opioids
Contrary to the belief that people who misuse prescription opioids are doing the wrong thing, a recent Australian study has shown most people overuse opioids to manage symptoms such as pain and mental health conditions.
What pharmacists need to know about new prescribing pilots
On 19 February, NSW Premier Dominic Perrottet announced that a proposed pharmacist prescribing pilot would go ahead.
Stepping down safely: deprescribing gabapentinoids in practice
Pregabalin is used beyond its approved indications. Safety concerns means the focus is shifting to individualised deprescribing strategies.
What’s the impact of the upcoming insulin discontinuations?
The discontinuation of several insulin products will leave many patients struggling to adjust to new medicine strengths and devices.
Making antidepressant tapering safer and easier
In a significant advancement for patient-centred care, a team of pharmacists is reshaping the landscape of antidepressant deprescribing.
High interruption rates threaten patient safety
New research has found that pharmacists are interrupted at alarming rates when dispensing medicines.
Led by Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences, the...
